FDA Generative AI Regulatory Guidance — Framework for AI-Powered Devices
OVERVIEWThe FDA is developing comprehensive regulatory guidance for generative AI-enabled medical devices, including frameworks for competency-based assessment and pre-authorization pathways. Guidance addresses how to evaluate AI systems that can learn and adapt, distinguishing them from traditional fixed-algorithm medical devices. Key guidance elements include: defining what constitutes appropriate AI "competency" in clinical settings, establishing evidence requirements for generative AI systems, addressing adaptive algorithms that change post-authorization, and ensuring transparency about AI decision-making. The FDA is considering competency-based approaches—where AI systems are evaluated similarly to how physicians are licensed and privileged—rather than fixed performance thresholds. This represents a regulatory evolution acknowledging that AI systems require different evaluation frameworks than traditional medical devices. UPDATED: Guidance framework is being finalized with input from industry, healthcare organizations, and patient advocates, with expected publication in 2026-2027. ---
Subscribe to read full wiki analysis
Full wiki content — including source provenance, contradiction tracking, related pages, and analyst notes — is available to Subscriber members.
View Plans & SubscribeNew users get a 7-day trial — no credit card required.